Spironolactone
Product Images NDC 67046-717

4 FDA label images from Contract Pharmacy Services-pa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 67046-717). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25aa223c-figure-01 (Spironolactone Tablets Usp 1)

25aa223c-figure-01 (Spironolactone Tablets Usp 1)
Chemical structure diagram of spironolactone, showing its steroid backbone with attached functional groups including a thioacetyl and a lactone ring.*
FDA Label Image

25aa223c-figure-02 (Spironolactone Tablets Usp 2)

25aa223c-figure-02 (Spironolactone Tablets Usp 2)
A survival probability plot comparing Spironolactone and placebo groups over a period of 42 months. The y-axis represents probability from 0.0 to 1.0, and the x-axis represents time in months. Two curves are shown: one for Spironolactone (n=822) and one for placebo (n=841), with the Spironolactone group showing higher survival probability. The plot indicates a statistically significant difference with a log-rank p-value of less than 0.001.*
FDA Label Image

25aa223c-figure-03 (Spironolactone Tablets Usp 3)

25aa223c-figure-03 (Spironolactone Tablets Usp 3)
A forest plot chart illustrating hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups such as age, sex, race, LVEF, heart failure type, NYHA class, diabetes, serum creatinine, creatinine clearance, potassium levels, digoxin, ACE inhibitors, and beta blocker usage. The horizontal axis ranges from 0.2 to 1.4, indicating Spironolactone versus placebo effect across different patient subgroups with sample sizes (N) listed.*
FDA Label Image

25aa223c-figure-04 (Spironolactone Tablets Usp 4)

25aa223c-figure-04 (Spironolactone Tablets Usp 4)
Spironolactone 25 mg tablet label showing a quantity of 30 tablets. The label includes storage instructions at 20-25°C (68-77°F) and states usual adult dosage instructions refer to attached literature. The product is packaged by Contract Pharmacy Services-PA with NDC 67046-717-30 and includes lot number, pill ID, and expiration date information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.